Form4insider filings, from the source

SEC Form 4 · accession 0001363763-16-000027

RespireRx Pharmaceuticals Inc. · RSPI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Arnold Lippa
Officer — Executive Chairman and CSO · Director
Period of report
Jun 16, 2016
Accepted (ET)
Jun 20, 2016 · 7:53 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000849636

Table I — non-derivative securities

No Table I lines on this filing.

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Common Stock Options (to purchase shares of Common Stock)F1,F3$0.025Jun 16, 2016J15,000,000D—Jun 30, 2022Common Stock15,000,0000D
Common Stock Options (to purchase shares of Common Stock)F1,F4$0.0197Jun 16, 2016J10,000,000D—Aug 18, 2022Common Stock10,000,0000D
Common Stock Options (to purchase shares of Common Stock)F2,F5$0.0227Jun 16, 2016J24,000,000D—Mar 31, 2021Common Stock24,000,0000D

Explanation of responses